GSK Plc (GSK)
GSK Market Cap : 118.03B for Feb. 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AstraZeneca PLC | 599.03B |
| Mereo BioPharma Group Plc | 64.51M |
| Biodexa Pharmaceuticals Plc | 1.065M |
| NuCana Plc | 9.239M |
| AnaptysBio, Inc. | 1.389B |
Market Cap Related Metrics
| PE Ratio | 16.05 |
| PS Ratio | 2.803 |
| PEG Ratio | 0.1220 |
| Price to Book Value | 5.358 |
| Price to Free Cash Flow | 21.15 |
| Price | 58.82 |
| Earnings Yield | 6.23% |
| PEGY Ratio | 0.1194 |
| Operating PE Ratio | 12.42 |
| Normalized PE Ratio | 14.87 |